MaxCyte, Inc.MXCTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank92
3Y CAGR+6.9%
5Y CAGR+17.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+6.9%/yr
vs +29.0%/yr prior
5Y CAGR
+17.6%/yr
Recent deceleration
Acceleration
-22.1pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.22M | -12.4% |
| 2024 | $7.10M | +49.7% |
| 2023 | $4.74M | -7.0% |
| 2022 | $5.10M | +39.8% |
| 2021 | $3.65M | +31.8% |
| 2020 | $2.77M | +10.7% |
| 2019 | $2.50M | +35.8% |
| 2018 | $1.84M | +26.6% |
| 2017 | $1.45M | +11.1% |
| 2016 | $1.31M | - |